You are here: Industry Insights > Biology

News List

Decoding the Role of Synthetic Biology in Pharmaceuticals Neeta Ratanghayra
October 16, 2024
Recognized for its transformative potential, synthetic biology has emerged as a technology poised to revolutionize various industries, including pharmaceuticals.
iotaSciences Raises Equity Financing Round to Drive Further Business Expansion for Its Automated Single-Cell Biology Handling Technologies Biotech Newswire
August 01, 2024
New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform.
Engineering the Cure: Advancement in Molecular Biology is building better drugs Shruti Talashi
March 18, 2024
Molecular biology holds the capacity to impact nearly every facet of drug research, development, and utilization.
Advancements in the field of synthetic biology in 2023 by ChatGPT ChatGPT
October 20, 2023
Synthetic biology is a multidisciplinary field that combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems.
iotaSciences Launches New isoPick™ Single-Cell Picker to Further Expand Handling Solutions for Efficient Cell Biology & Gene Therapy Applications PharmaSources
February 07, 2023
First isoPick™ showcases at upcoming ELRIG CRISPR IN DRUG DISCOVERY 2023 event in Oxford (UK) and SLAS 2023 meeting in San Diego (USA).
Reaction Biology Announces Integrated Drug Discovery Solutions: The Reaction Oncology Platform B3Cnewswire
February 07, 2022
Reaction Biology, a solution provider for discovering small molecules for 20 years, has created a comprehensive platform for integrated drug discovery comprising target research...
Piramal to create screening facility to boost in-vitro biology capabilities CPhIonline
January 14, 2022
The move is expected to bring added value to customers by coupling biology services with existing chemistry capabilities.
ATP Launches Adendra Therapeutics, an Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology AmericanPharmaceuticalReview
December 09, 2021
ATP (Apple Tree Partners), a life sciences venture capital company, announced the launch of Adendra Therapeutics Ltd., a company that will discover and develop treatments for cancers and autoimmune diseases by applying new insights into regulation of...
OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology prnasia
July 21, 2021
OriCiro Genomics announced that it has raised ¥800 million in Series B financing led by The University of Tokyo Edge Capital Partners (UTEC) with participation of ITOCHU Technology Ventures (ITV).
Synthetic Biology Startup Allozymes Raises US $5 Million Seed Round to Deliver Sustainable, Scalable Manufacturing of Natural Ingredients prnasia
July 21, 2021
Allozymes, a Singapore-based, synthetic biology startup, announced today that it has raised US $5 million in a seed financing round led by Xora Innovation, the deep science investment arm of Temasek Holdings.